Back in action in Salt Lake City to enter the post All-Star stretch of the season 📍 @NickAGallo and @ParisNLawson prep you for the game in today’s @OUHealth Game Day Report 📝

New #OUResearch is pioneering a new blood test that could revolutionize early detection for cancer. Partnering with @GrailBio, researchers at the @StephensonCC are studying a test that may identify over 50 types of cancer before they spread. Learn more: https://t.co/LuGI2We9jR

Dr. Motolani (Ogunsanya) Adedipe, an OU researcher from the @StephensonCC, has received a $1.3M grant from the @DeptofDefense to test a new mobile app designed to address health disparities among Black men with prostate cancer. Read more: https://t.co/rLwIdBexY5

“In the United States, Black men are …diagnosed with prostate cancer at a 60% higher rate than white men…” @StephensonCC researcher, Dr. Motolani (Ogunsaya) Adedipe, is working to address these disparities with a new app with a @DeptofDefense grant. #LeadOn Dr. Adedipe!

Journey Ends for Upifitamab Rilsodotin in NaPi2b+ Platinum-Resistant Ovarian Cancer @debbieric23 @StephensonCC @oucollegeofmed @OUHealth @sgo_org #SGOMtg #gyncsm https://t.co/poA0lShQw9

Want to hear more about the UPLIFT trial and the evaluation of upifitamab rilsodotin in #OvarianCancer? Check back to https://t.co/NFJ4GmvcEW to hear more from Dr Richardson, of @StephensonCC, on the topic: https://t.co/uAslW4llld

Debra L. Richardson, MD, FACS, FACOG, expands on results with upifitamab rilsodotin in platinum-resistant high-grade serous ovarian cancer. @debbieric23 @StephensonCC @oucollegeofmed @OUHealth @sgo_org #SGOMtg #gyncsm

Every cancer journey is unique, and not all therapies lead to success. Thanks to Abdul Rafeh Naqash, M.D. from @StephensonCC, breakthroughs are happening with his research meaning more patients could receive personalized care tailored to their needs. 🔗 https://t.co/Q0pnHA7zTb

Groundbreaking #OUResearch from @StephensonCC delves into the intricate role of vitamin B6 in pancreatic cancer. @OUCollegeofMed's Dr. Kamiya Mehla aims to boost the body's immune system against cancer's relentless pursuit of this essential vitamin. 🔗 https://t.co/ZQU6THded9

Congratulations to OU Health Stephenson Cancer Center in OKC for your selection by the National Institutes of Health to provide research on emerging cancer screenings to help with early detection.

Center of Excellence for Rectal Cancer Accreditation Earned by OU Health Stephenson Cancer Center https://t.co/NRLgoSzV0O

STAAR Ovarian Cancer funds combination drug trial for low-grade serous ovarian cancer https://t.co/kaRBTxifXY

This effort is called the Oklahoma Tribal, Rural, Urban Cancer Screening Trial (OK TRUST) Access Hub, and it will help us to expand the number of Oklahomans with access to these tools.

Joining this network will give our patients access to groundbreaking screening clinical trials that can detect cancer before a person has symptoms.

.@OUHealth Stephenson Cancer Center at @UofOklahoma Health Sciences joins just eight other groups nationwide to receive funding to participate in the @theNCI cancer screening research network. https://t.co/SpLD46M8x2

TSET partners with 3 incredible research programs: the @StephensonCC, the Health Promotion Research Center and the Oklahoma Center for Adult Stem Cell Research. Learn more about each of them here: https://t.co/SZrStk3e3V

.@StephensonCC is proud to join @theNCI's Cancer Screening Research Network. Together, we're exploring groundbreaking research, funded by the @NIH, to enhance cancer screening for Oklahomans facing higher cancer risk and limited access. Learn more: https://t.co/JjDhyhtEhI

OU Health Sciences and @StephensonCC have launched the Scientific Training in Oncology (STRONG) program! This initiative, made possible by @AmericanCancer, aims to provide unique career opportunities while fostering diversity in cancer research. 🔗 https://t.co/gu3Pvo2phS

#OUResearch in the News: Groundbreaking research from OU Health Sciences could save countless lives. Featured on @kfor, OU researchers from the @StephensonCC discuss a first-of-its-kind study aimed at revolutionizing the detection of pancreatic cancer. https://t.co/mwN4Ek4hLC

Preclinical Study Reveals Potential Role for GLP-Agonists in Endometrial Cancer @DKrauseMD @StephensonCC #gyncsm #oncology #MedTwitter https://t.co/jntJT0bBWA